Supriya Lifescience Ltd Share Price Results

Stocks

Supriya Lifescience Ltd Share Price

Results

Quarterly results

Show figures in :

Quarterly results

Quarter ended on March 31, 2025Data in Crores of INR

Revenue

₹ 184.11+16.39% from last year

Operating profits

₹ 70.56+22.31% from last year

Net income

₹ 50.38+36.42% from last year

Financial reports

Data is unavailable

	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Net worth	815.37	699.46	615.69	268.58	149.19	93.79	54.66	45.89	41.72
Fixed assets	310.13	261.54	189.77	100.04	97.99	84.68	91.01	88.78	75.45
Debt	-	16.63	21.30	70.13	82.21	89.84	130.37	140.08	129.10

View detailed balance sheet

	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014
Operating	113.31	63.61	48.80	75.89	116.06	48.88	27.75	27.30	13.50	-6.25	5.10
Investing	-173.58	-123.65	-59.82	-46.80	-24.53	4.83	-4.71	-26.61	-32.83	-23.22	-13.66
Financing	-22.36	-10.28	149.65	-14.52	-29.23	-49.93	-20.01	-2.21	21.36	30.22	9.81

Financial ratios

Profitability ratios info2

ROA13.66%

ROE15.73%

ROCE22.31%

EPS14.8%

Net profit margin20.88%

Operating profit margin28.85%

Dividend per share0.8%

Operational ratios info2

Quick ratio3.96%

Current ratio5.03%

Interest coverage33.18%

Assets turnover0.74%

Debt to equity

Valuation ratios info2

P/E ratio30.99%

P/B ratio

Dividend yield0.14%

EV/EBITDA

Supriya Lifescience Limited is one of the key Indian manufacturers and suppliers of active pharmaceuticals ingredients (APIs), with a focus on research and development. The company has niche product offerings of various APIs focused on diverse therapeutic segments such as antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic and antiallergic. The company’s pharmaceutical business is organized into domestic and export sales, according to the geographies in which it operates. It has grown its API business in several countries across Europe, Latin America, Asia (excluding India), North America and India.

Grow your wealth with more research recommendations

+91

We're all set for a new experience. To visit the old Ventura website, click here.

Ventura Wealth Clients Login here

Quarterly results

Quarterly results

Financial reports

Financial ratios

Grow your wealth with more research recommendations

Corporate Address